Nephron . COVID-19 Infection: Viral Clearance and Antibody Response in Dialysis Patients and Renal Transplant Recipients

[tetano]

Nephron


. 2021 Apr 26;1-8.
doi: 10.1159/000515128. Online ahead of print.
COVID-19 Infection: Viral Clearance and Antibody Response in Dialysis Patients and Renal Transplant Recipients


Paolo Ferdinando Bruno ¹ , Maria Cappuccilli ² , Alessandra Spazzoli ¹ , Matteo De Liberali ³ , Brunilda Sejdiu ⁴ , Marianna Napoli ² , Vera Minerva ² , Simona Semprini ⁵ , Giorgio Dirani ⁵ , Vittorio Sambri ⁵ , Andrea Buscaroli ⁴ , Angelo Rigotti ³ , Elena Mancini ⁶ , Paolo Masperi ⁷ , Gaetano La Manna ² , Giovanni Mosconi ¹



Affiliations

• PMID: 33902031
• DOI: 10.1159/000515128

Abstract

Background/aims: The coronavirus disease 2019 (CO-VID-19) pandemic is the major current health emergency worldwide, adding a significant burden also to the community of nephrologists for the management of their patients. Here, we analyzed the impact of COVID-19 infection in renal patients to assess the time to viral clearance, together with the production and persistence of IgG and IgM antibody response, in consideration of the altered immune capacity of this fragile population.
Methods: Viral clearance and antibody kinetics were investigated in 49 renal patients recovered from COVID-19 infection: 7 of them with chronic decompensated renal failure, 31 under dialysis treatment, and 11 kidney transplant recipients.
Results: The time span between the diagnosis of infection and recovery based on laboratory testing (2 negative nasopharyngeal swabs in consecutive days) was 31.7 ? 13.3 days. Three new positive cases were detected from 8 to 13 days following recovery. At the first serological determination after swab negativization, all the patients developed IgG and IgM antibodies. The semiquantitative analysis showed a progressive increase in IgG and a slow reduction in IgM.
Discussion/conclusion: In subjects with decompensated chronic kidney disease, under dialysis and in transplant recipients, viral clearance is lengthened compared to the general population. However, in spite of their common status of immunodepression, all of them were able to produce specific antibodies. These data might provide useful insights for monitoring and planning health-care activities in the weak category of patients with compromised renal function recovered from COVID-19.

Keywords: Chronic renal failure; Coronavirus disease 2019; Dialysis; Kidney transplantation; Viral clearance.